We're submitting a case to The National Institute for Health and Care Excellence (NICE) to advocate for new chronic lymphocytic leukaemia (CLL) treatments on behalf of patients. But before we do we need you to share your experience of CLL treatments.
Let us know your thoughts by completing our survey 👉bit.ly/3uFERjq
Week 2 Obinutuzumab 
Not sure if I’m vulnerable or not 
Acute lymphoblastic leukaemia 
Experiences with Ibrutinib?